Schizophrenia is a life-shortening disease and life expectancy in patients may be 15–20
years shorter than in the general population, with increasing longevity gap over time …

BACKGROUND As the burden of mental disorders among patients with atrial fibrillation (AF)
increases, researchers are beginning to pay close attention to the risk and prevalence of …

Patients with severe mental disorders such as bipolar disorder (BD), schizophrenia (SCZ)
and major depressive disorder (MDD) show a substantial reduction in life expectancy …

Introduction The true global burden of vascular cognitive impairment (VCI) is unknown.
Reducing risk factors for stroke and cardiovascular disease would inevitably curtail VCI …

Introduction Antipsychotics are the foundation of pharmacologic treatment for schizophrenia.
There are many oral antipsychotics available and given that these medications are generally …

BackgroundIndividuals with serious mental illness have a markedly shorter life expectancy.
A major contributor to premature death is cardiovascular disease (CVD). We investigated …

Background There are few data on sex differences in the association between
schizophrenia and the development of cardiovascular disease (CVD). We sought to clarify …

A correlation between mental illness and systemic rheumatoid arthritis (RA) has been
observed in several prior investigations. However, little is known about the causative …

Exosomes, as gifts of nature derived from various cell types with a size range from~ 40 to
160 nm in diameter, have gained attention recently. They are composed of a lipid membrane …

Patient-centered care is gaining widespread acceptance by the medical and lay
communities and is increasingly recognized as a goal of high-quality health care delivery …